Literature DB >> 2835069

Doxorubicin and 4'-epidoxorubicin in combination chemotherapy of extensive small cell lung cancer.

T A Nikkanen1, M Jakobsson, M Järvinen, K Liippo, A Ojala, S Paloheimo, E Nordman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2835069     DOI： 10.3109/02841868809090324

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

Review 1.  Different anthracycline derivates for reducing cardiotoxicity in cancer patients.

Authors:  Elvira C van Dalen; Erna Mc Michiels; Huib N Caron; Leontien Cm Kremer
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

2.  Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG).

Authors:  S Eckhardt; K Kolaric; D Vukas; E Kánitz; Z Schoket; J Jassem; L Vuletic; S Jelic; Z Mechl; I Koza
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 3.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.